Pfm Health Sciences, LP Intellia Therapeutics, Inc. Transaction History

Pfm Health Sciences, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $9.79 Million - $13 Million	181,588 Added 111.21%	344,868 $19.3 Million
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $4.8 Million - $9.5 Million	-124,629 Reduced 43.29%	163,280 $8.45 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $6.39 Million - $13.1 Million	109,687 Added 61.55%	287,909 $20.9 Million
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $6.45 Million - $17.1 Million	-105,879 Reduced 37.27%	178,222 $28.9 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $13.2 Million - $23.8 Million	284,101 New	284,101 $22.8 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.